Dr. Michael Chow, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $683.42 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $259.04 | 14 | $0 (2024) |
| Davol Inc. | $258.67 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $86.77 | 6 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $28.57 | 2 | $0 (2019) |
| PFIZER INC. | $24.02 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $13.85 | 1 | $0 (2021) |
| SI-BONE, INC. | $12.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.33 | 6 | ABBVIE INC. ($106.33) |
| 2023 | $381.72 | 9 | Davol Inc. ($258.67) |
| 2022 | $73.60 | 4 | Janssen Pharmaceuticals, Inc ($43.94) |
| 2021 | $54.26 | 4 | Janssen Pharmaceuticals, Inc ($27.91) |
| 2019 | $40.41 | 3 | PORTOLA PHARMACEUTICALS, INC. ($28.57) |
| 2018 | $27.10 | 2 | Janssen Pharmaceuticals, Inc ($14.92) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/08/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/07/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/22/2023 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $147.18 | General |
| Category: Surgery | ||||||
| 12/19/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/07/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/31/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/26/2023 | Davol Inc. | — | Food and Beverage | In-kind items and services | $111.49 | General |
| 05/24/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/03/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 10/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 09/20/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,161 | 1,191 | $1.3M | $119,652 |
| 2022 | 8 | 1,302 | 1,354 | $1.4M | $140,353 |
| 2021 | 9 | 1,495 | 1,575 | $1.6M | $157,177 |
| 2020 | 8 | 1,276 | 1,346 | $1.4M | $130,746 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 436 | 452 | $785,124 | $68,330 | 8.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 220 | 227 | $264,682 | $22,974 | 8.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 119 | 119 | $232,288 | $22,307 | 9.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 25 | $24,400 | $2,389 | 9.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 23 | 24 | $18,768 | $1,461 | 7.8% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 227 | 229 | $21,297 | $1,306 | 6.1% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 95 | 95 | $2,185 | $705.94 | 32.3% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 20 | 20 | $580.00 | $178.80 | 30.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 504 | 527 | $915,399 | $86,161 | 9.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 137 | 138 | $269,376 | $30,330 | 11.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 119 | 123 | $143,418 | $12,821 | 8.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 37 | 46 | $44,896 | $5,125 | 11.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 46 | 46 | $35,972 | $2,851 | 7.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 232 | 243 | $23,328 | $1,621 | 7.0% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 131 | 135 | $12,555 | $774.35 | 6.2% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 96 | 96 | $2,208 | $669.10 | 30.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 583 | 622 | $1.1M | $103,954 | 9.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 125 | 129 | $251,808 | $28,678 | 11.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 128 | 133 | $155,078 | $14,218 | 9.2% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 25 | 33 | $31,232 | $3,662 | 11.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 391 | 413 | $39,648 | $2,848 | 7.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 39 | 39 | $30,498 | $2,327 | 7.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2021 | 138 | 140 | $3,220 | $993.14 | 30.8% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2021 | 50 | 50 | $4,650 | $280.59 | 6.0% |
| 74022 | Complete x-ray study of abdomen with single x-ray of chest | Facility | 2021 | 16 | 16 | $1,696 | $216.80 | 12.8% |
About Dr. Michael Chow, D.O
Dr. Michael Chow, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Trenton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720286628.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chow, D.O has received a total of $683.42 in payments from pharmaceutical and medical device companies, with $106.33 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($683.42).
As a Medicare-enrolled provider, Chow has provided services to 5,234 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $547,928. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Emergency Medicine
- Location Trenton, NJ
- Active Since 07/03/2007
- Last Updated 11/15/2011
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1720286628
Products in Payments
- DALVANCE (Drug) $208.05
- ARISTA AH FlexiTip (Device) $147.18
- XARELTO (Drug) $86.77
- TEFLARO (Drug) $50.99
- ANDEXXA (Biological) $28.57
- ELIQUIS (Drug) $24.02
- LOKELMA (Drug) $13.85
- IFUSE IMPLANT (Device) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Trenton
Asher Hussain, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,817
Jacob Hamad, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $1,468
Dr. Rabia Soomro, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,221
Ranjodh Singh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $891.57
Dennis Hogan, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $794.17
Dr. Lauren Levine, D.m.d, D.M.D
Student in an Organized Health Care Education/Training Program — Payments: $353.46